Global Regenerative Medicine Market Professional Survey Report 2016

Published: May, 2016 | Pages: 177 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Global regenerative medicine market is witnessing a transitional phase in the recent years and continues to evolve rapidly in the assessment period. Regenerative medicine is a novel scientific approach emphasizing on harnessing the power of stem cells and body’s own regenerative competencesto regain function to damaged cells, organs and tissues. Intensive research is conducted to grasp why and how several types of cells have ability to mature into specialized tissues and cells.

Additionally, regenerative medicine is also inclusive of tissue engineering. Bioengineers along with biologists, nano technologists, physicians and other specialties are working upon connecting tissues and potential organs or scaffolds made of biological materials to resemble cartilage, bone and other structure that supports tissue and organ growth.

Regenerative medicine also helps in understanding and promoting the ability of an organ or tissue to repair by self. Several adult tissues contain stem cells, but stem cell are dysfunctional or impaired by disease. By using certain factors to trigger and promote essential processes in a diseased organ to unlock many novel therapies towards degenerative diseases.

On a commercial scale, many scientists are utilizing regenerative medicine approaches to rebuild stem cells and tissues and in some clinical trials, practicing novel therapies is a gateway to modern way of treating degenerative diseases. Hence, regenerative medicine as a part of intrinsic therapy is gaining traction presently and the global regenerative medicine market is anticipated to grow at a higher CAGR during the forecast period.

The key driving factors responsible for the growth of regenerative medicine market includes government and private subsidy to assist development of regenerative medicine. Additionally, rising incidences of chronic diseases and genetic ailments, rise in global healthcare expenditure and massive growth in geriatric population is anticipated to fuel the market growth for forecast period. However, market entrants and product failures are likely to impede market growth during the forecast period.

Global regenerative medicine market is segmented into cell-based products and acellular products, based on type. Global regenerative medicine market is segmented into cell therapy, gene therapy, tissue engineering and immunotherapy, based on therapy. Global regenerative medicine market is segmented into orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system disease, ocular, autoimmune, rare diseases and dental/oral diseases.

Global regenerative medicine market spans North America, Latin America, Europe, Asia-Pacific, Middle-East & Africa. North America is anticipated to grow at a higher CAGR during the forecast period. APAC regions are anticipated to rise at a higher CAGR owing to rise in research activities in Asian countries, availability of funding for research and establishment of research centers responsible for the APAC market growth. The key players in the global regenerative medicine market include Organogenesis Inc, Osiris Therapeutics Inc, Vericel Corporation Inc, Stryker Corporation, NuVasive Inc, Medtronic, Acelity, Integra LifeSciences, Cook Biotech Inc and C.R. Bard.

 Table of Contents

1 Industry Overview of Regenerative Medicine
1.1 Definition and Specifications of Regenerative Medicine
1.1.1 Definition of Regenerative Medicine
1.1.2 Specifications of Regenerative Medicine
1.2 Classification of Regenerative Medicine
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Regenerative Medicine
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Commercial use
1.4 Industry Chain Structure of Regenerative Medicine
1.5 Industry Overview and Major Regions Status of Regenerative Medicine
1.5.1 Industry Overview of Regenerative Medicine
1.5.2 Global Major Regions Status of Regenerative Medicine
1.6 Industry Policy Analysis of Regenerative Medicine
1.7 Industry News Analysis of Regenerative Medicine

2 Manufacturing Cost Structure Analysis of Regenerative Medicine
2.1 Raw Material Suppliers and Price Analysis of Regenerative Medicine
2.2 Equipment Suppliers and Price Analysis of Regenerative Medicine
2.3 Labor Cost Analysis of Regenerative Medicine
2.4 Other Costs Analysis of Regenerative Medicine
2.5 Manufacturing Cost Structure Analysis of Regenerative Medicine
2.6 Manufacturing Process Analysis of Regenerative Medicine

3 Technical Data and Manufacturing Plants Analysis of Regenerative Medicine
3.1 Capacity and Commercial Production Date of Global Regenerative Medicine Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Regenerative Medicine Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Regenerative Medicine Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Regenerative Medicine Major Manufacturers in 2015

4 Global Regenerative Medicine Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Regenerative Medicine Capacity and Growth Rate Analysis
4.2.2 2015 Regenerative Medicine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Regenerative Medicine Sales and Growth Rate Analysis
4.3.2 2015 Regenerative Medicine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Regenerative Medicine Sales Price
4.4.2 2015 Regenerative Medicine Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Regenerative Medicine Gross Margin
4.5.2 2015 Regenerative Medicine Gross Margin Analysis (Company Segment)

5 Regenerative Medicine Regional Market Analysis
5.1 USA Regenerative Medicine Market Analysis
5.1.1 USA Regenerative Medicine Market Overview
5.1.2 USA 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Regenerative Medicine Sales Price Analysis
5.1.4 USA 2015 Regenerative Medicine Market Share Analysis
5.2 China Regenerative Medicine Market Analysis
5.2.1 China Regenerative Medicine Market Overview
5.2.2 China 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Regenerative Medicine Sales Price Analysis
5.2.4 China 2015 Regenerative Medicine Market Share Analysis
5.3 UK Regenerative Medicine Market Analysis
5.3.1 UK Regenerative Medicine Market Overview
5.3.2 UK 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Regenerative Medicine Sales Price Analysis
5.3.4 UK 2015 Regenerative Medicine Market Share Analysis
5.4 France Regenerative Medicine Market Analysis
5.4.1 France Regenerative Medicine Market Overview
5.4.2 France 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Regenerative Medicine Sales Price Analysis
5.4.4 France 2015 Regenerative Medicine Market Share Analysis
5.5 Switzerland Regenerative Medicine Market Analysis
5.5.1 Switzerland Regenerative Medicine Market Overview
5.5.2 Switzerland 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Regenerative Medicine Sales Price Analysis
5.5.4 Switzerland 2015 Regenerative Medicine Market Share Analysis
5.6 Japan Regenerative Medicine Market Analysis
5.6.1 Japan Regenerative Medicine Market Overview
5.6.2 Japan 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Regenerative Medicine Sales Price Analysis
5.6.4 Japan 2015 Regenerative Medicine Market Share Analysis
5.7 Germany Regenerative Medicine Market Analysis
5.7.1 Germany Regenerative Medicine Market Overview
5.7.2 Germany 2011-2016E Regenerative Medicine Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Regenerative Medicine Sales Price Analysis
5.7.4 Germany 2015 Regenerative Medicine Market Share Analysis

6 Global 2011-2016E Regenerative Medicine Segment Market Analysis (by Type)
6.1 Global 2011-2016E Regenerative Medicine Sales by Type
6.2 Different Types Regenerative Medicine Product Interview Price Analysis
6.3 Different Types Regenerative Medicine Product Driving Factors Analysis
6.3.1 Injection Regenerative Medicine Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Regenerative Medicine Growth Driving Factor Analysis

7 Global 2011-2016E Regenerative Medicine Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Regenerative Medicine Growth Driving Factor Analysis
7.3.2 Clinic Regenerative Medicine Growth Driving Factor Analysis
7.3.3 Commercial use Regenerative Medicine Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Regenerative Medicine
8.1 AlloSource
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 AlloSource 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AlloSource 2015 Regenerative Medicine Business Region Distribution Analysis
8.2 Anika Therapeutics
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Anika Therapeutics 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Anika Therapeutics 2015 Regenerative Medicine Business Region Distribution Analysis
8.3 Biomet
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Biomet 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Biomet 2015 Regenerative Medicine Business Region Distribution Analysis
8.4 Bioventus LLC
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Bioventus LLC 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Bioventus LLC 2015 Regenerative Medicine Business Region Distribution Analysis
8.5 DePuy Synthes Companies
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 DePuy Synthes Companies 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 DePuy Synthes Companies 2015 Regenerative Medicine Business Region Distribution Analysis
8.6 DePuy Spine
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 DePuy Spine 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 DePuy Spine 2015 Regenerative Medicine Business Region Distribution Analysis
8.7 Exactech
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Exactech 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Exactech 2015 Regenerative Medicine Business Region Distribution Analysis
8.8 Histogenics Corp.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Histogenics Corp. 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Histogenics Corp. 2015 Regenerative Medicine Business Region Distribution Analysis
8.9 Integra LifeSciences Holdings Corp
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Integra LifeSciences Holdings Corp 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Integra LifeSciences Holdings Corp 2015 Regenerative Medicine Business Region Distribution Analysis
8.10 LifeCell Corporation
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 LifeCell Corporation 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 LifeCell Corporation 2015 Regenerative Medicine Business Region Distribution Analysis
8.11 LifeNet Health
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 LifeNet Health 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 LifeNet Health 2015 Regenerative Medicine Business Region Distribution Analysis
8.12 Medtronic
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Medtronic 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Medtronic 2015 Regenerative Medicine Business Region Distribution Analysis
8.13 NovaBone Products LLC
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 NovaBone Products LLC 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 NovaBone Products LLC 2015 Regenerative Medicine Business Region Distribution Analysis
8.14 NuVasive
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 NuVasive 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 NuVasive 2015 Regenerative Medicine Business Region Distribution Analysis
8.15 Orthofix International N.V.
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Orthofix International N.V. 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Orthofix International N.V. 2015 Regenerative Medicine Business Region Distribution Analysis
8.16 Osiris Therapeutics
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Osiris Therapeutics 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Osiris Therapeutics 2015 Regenerative Medicine Business Region Distribution Analysis
8.17 Smith & Nephew Plc
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Smith & Nephew Plc 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Smith & Nephew Plc 2015 Regenerative Medicine Business Region Distribution Analysis
8.18 Stryker Corporation
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Stryker Corporation 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Stryker Corporation 2015 Regenerative Medicine Business Region Distribution Analysis
8.19 TiGenix N.V.
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 TiGenix N.V. 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 TiGenix N.V. 2015 Regenerative Medicine Business Region Distribution Analysis
8.20 Wright Medical Technology
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Wright Medical Technology 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Wright Medical Technology 2015 Regenerative Medicine Business Region Distribution Analysis
8.21 BioMimetic Therapeutics LLC
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 BioMimetic Therapeutics LLC 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 BioMimetic Therapeutics LLC 2015 Regenerative Medicine Business Region Distribution Analysis
8.23 Zimmer Holdings
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Zimmer Holdings 2015 Regenerative Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Zimmer Holdings 2015 Regenerative Medicine Business Region Distribution Analysis

9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Regenerative Medicine Consumption Forecast
9.2.2 China 2016-2021 Regenerative Medicine Consumption Forecast
9.2.3 UK 2016-2021 Regenerative Medicine Consumption Forecast
9.2.4 France 2016-2021 Regenerative Medicine Consumption Forecast
9.2.5 Switzerland 2016-2021 Regenerative Medicine Consumption Forecast
9.2.6 Japan 2016-2021 Regenerative Medicine Consumption Forecast
9.2.7 Germany 2016-2021 Regenerative Medicine Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 Regenerative Medicine Marketing Model Analysis
10.1 Regenerative Medicine Regional Marketing Model Analysis
10.2 Regenerative Medicine International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Regenerative Medicine by Regions
10.4 Regenerative Medicine Supply Chain Analysis

11 Consumers Analysis of Regenerative Medicine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 New Project Investment Feasibility Analysis of Regenerative Medicine
12.1 New Project SWOT Analysis of Regenerative Medicine
12.2 New Project Investment Feasibility Analysis of Regenerative Medicine

13 Conclusion of the Global Regenerative Medicine Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.